McNeil Consumer Pharmaceuticals Co
McNeil Consumer Pharmaceuticals Co., a subsidiary of Johnson & Johnson, is a prominent player in the pharmaceutical industry, headquartered in the United States. Founded in 1959, the company has established itself as a leader in over-the-counter (OTC) medications, focusing on areas such as pain relief, allergy treatment, and digestive health. With a diverse portfolio that includes well-known products like Tylenol, Motrin, and Pepcid, McNeil is recognised for its commitment to quality and consumer trust. The company has achieved significant milestones, including the development of innovative formulations that cater to various health needs. As a key contributor to the OTC market, McNeil Consumer Pharmaceuticals Co. continues to uphold its reputation for excellence, making it a trusted choice for consumers seeking effective healthcare solutions.
DitchCarbon Score
How does McNeil Consumer Pharmaceuticals Co's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
McNeil Consumer Pharmaceuticals Co's score of 34 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
McNeil Consumer Pharmaceuticals Co's reported carbon emissions
McNeil Consumer Pharmaceuticals Co, headquartered in the US, currently does not have publicly available carbon emissions data or specific reduction targets. Without emissions figures, it is challenging to assess their carbon footprint or climate commitments. However, the company may be engaged in industry-standard practices aimed at reducing environmental impact, although specific initiatives or pledges have not been disclosed. As the landscape of corporate sustainability evolves, it is essential for companies like McNeil to establish clear climate commitments and measurable targets to contribute effectively to global emissions reduction efforts.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
McNeil Consumer Pharmaceuticals Co is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
